ABSTRACT 3 H-Androst-5-ene-17-one-3B-pl sulfate is converted to 3B-androst-5-ene-lW-ol-3f3-yl sulfate by soluble extracts of rat testis in the presence of added NAM%2 or NADPH2. The conversion was approximately 4 times greater than the conversion of 3H-androst-5-ene-17-one-3B_ol to 3%androst-5-ene+3@,17&diol
INTRODUCTION
In an earlier report from this laboratory2, iL was demonstrated that soluble enzyme preparations from several endocrine tissues, i.e., rat testis and bovine adrenal cortex, ovary, and corpus luteum, sulfurylate estradiol-1?$3. Recent in vivo 3*4*5 and in vitro a,7 studies __I_ _I-demonstrating that steroid sulfates can serve as metabolic intermediates led us to investigate whether the abovementioned preparations also catafyze metabolic interconversions of steroid sulfates. In the present investigation it was demonstrated that these preparations sulfurylate dehydroepiandrosterone and that they convert dehydroepiandrosterone sulfate to androst-5-enediol-3-sulfate, Possible relations of these observations to the in vivo conversion of dehydroepi---androsterone and its sulfate to testosterone are discussed.
EXPERIMENTAL
Materials 7a-3H-Dehydroepiandrosterone (DBA) (1.15 c/mM) and the ammonium salt of 7u-3H-Dehydroepiandrosterone sulfate (DHA-S) (1.7 c/mM) were purchased from New England Nuclear Corporation. DHA-S was purified by paper chromatography in 0.4 M NaHC032. The purity of DHA was checked by paper chromatography in hexane-benzene/formamide. Androst-5-ene-3B,17S-diol, dehydroepiandrosterone, NADH2 and NADPH2 were obtained from Sigma Chemical Company.
Preparation of carrier sulfates
DHA was sulfurylated by a modification of the method described by Morren8. Pyridine (4.2 ml) was added dropwise with shaking to 1.5 ml of chlorosulfonic acid in 60 ml of CC14. Three grams of DHA dissolved in a minimum amount of chloroform was added dropwise to the reaction mixture, The mixture was allowed to stand for 30 minutes in the cold, and then was heated on a steam bath for 30 minutes. After cooling the solid material was collected and stirred with a mixture of 25 ml of water and 13.5 ml of concentrated ammonium hydroxide. Pyridine was removed by ether extraction and residual ether was removed by evaporation.
Boiling water (65 ml) was added. The solution was heated to dissolve solid material and was then filtered and allowed to cool. The crystals were collected and dried. They were recrystallized from water.
The ammonium salt of androstenediol-3-sulfate was prepared by reducing DHA-S. Two g of the ammonium salt of DHA-S was dissolved in 50 ml methyl alcohol and the solution was cooled in ice. Sodium borohydride (200 mg) was added. The solution was then warmed to room temperature and allowed to stand overnight. Acetone (8 ml) was added to decompose the excess sodium borohydride. After addition of 2.4 ml of water the solution was placed in the freezer. The sodium metaborate which separated was filtered off, and the solution was evaporated to dryness. The residue was recrystallized from a mixture of methyl alcohol and ether.
The ammonium salt of androstenediol-3-sulfate-17-acetate was prepared from the ammonium salt of androstenediol-3-sulfate by dissolving the latter in pyridineacetic anhydride, 2:l (v/v) , and allowing the solution to stand overnight at room temperature. The excess reagent was removed under vacuum with slight warming and the residue recrystallized from a mixture of methanol and ether.
Melting points and infrared spectra of the DHA-S and androstenedio1-S preparations agreed well with those previously published5. Each compound migrated as a single component on paper chromatography in system SL-1 and, after solvolysis, in systems Z-l, Z-2 and Z-3 (see Results).
Incubation and extraction
Testes were obtained from Holtzman rats. Soluble extracts of the tissue were prepared, lyophylized, and stored at -loo as described earlierg.
Seven pc 3H-DHA-S (0.0226 pmoles) or 6.25 JX 3H-DHA (0.0171 pmoles) was incubated in a rotary agitator for 2 hrs at 37O in one ml of 0.2 M potassium phosphate buffer (pH 7.4) containing lyophylized testis extract equivalent to 10.5 mg of protein and 10 mg of NADH2 or NADPH2. The DHA was first dissolved in 0.03 ml of absolute ethanol before addition to the buffer solution. After incubation, the steroid sulfates and free steroids were extracted as described previously2.
Detection of steroids and measurement of radioactivity Radioactive compounds on chromatograms were localized with a Vanguard Autoscanner 880; authentic steroid sulfates were detected by the technique of Crepy and JudaslO, free steroids with phosphomolybdic acid reagentll. Radioactivity was measured in a Packard TriCarb scintillation spectrometer.
The scintillation solution consisted of 0.3% 2,5-diphenyloxazole (PPO) and 0.01% 1,4-bis-2-(5-phenyloxazolyl)-benzene (POPOP) in toluene (w/v).
Relative amounts of the radioactive products on chromatograms were determined by cutting out the specific area, submerging it in scintillation solution, and counting.
The specific activities of 3H-DHA-S and of 3H-androstenediol-3-sulfate-17-acetate was determined by dissolving weighed amounts of the crystals in a known volume of methanol and counting duplicate 0.2 ml aliquots in 7 ml of scintillation solution. Radioactivity is reported without correction for quenching. The solvolyzed products were eluted with methanol, the methanol evaporated, and the free steroids extracted three times from water into methylene chloride.
The methylene chloride was evaporated and the products applied to paper along with authentic DHA and androstenediol for chromatography ( Table 2) Since the substrate and one product were the only detectable radioactive compounds on chromatograms of these extracts, it seemed appropriate to express the extent of conversion to the product as a per cent of the sum of the counts/min of extracted product plus counts/min of extracted substrate. Per cent conversion Tables 2 and 3 The present study identifies rat testis as one tissue possessing enzymes capable of catalyzing the reduction of DHA-S to androstenediol-3-sulfate. It is probable that this activity is shared by other tissues that have 17-dehydrogenase activity. It occurs in tissues other than testis since it has been demonstrated in vivo in human females 335 . The reaction has --also been reported to occur in rabbit liver slices 22 .
We have found in preliminary studies that soluble extracts of bovine ovary also catalyze the reduction but were less active than the rat testis extracts.
Present speculation concerning the role of the The conversion of DRA-S into testosterone has been demonstrated by Aakvag et al. 33 in perfused canine testis --and ovary. However, the reaction sequence in this conversion was not demonstrated. They were unable to detect any free DHA in the spermatic vein after infusion of DHA-S into the spermatic artery, suggesting that DHA-S may be reduced to androstenediol-3-sulfate prior to the cleavage of the sulfate ester to the free steroid. The finding in the present study that DHA-S was converted to androstenediol-3-sulfate by rat testis extracts and that this conversion was much more efficient than the conversion of DHA to androstenediol provides support for this suggestion.
